Evaluation of the Effect of FertyBiotic Pregnancy in the Metabolic Profile in Pregnant Women
NCT ID: NCT04935840
Last Updated: 2025-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
84 participants
INTERVENTIONAL
2021-05-05
2026-03-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prenatal Probiotic Intervention
NCT03240419
Evaluation of the Colonization Capacity of a Probiotic Bacterium.
NCT05878444
Maternal & Offspring Microbiome Study
NCT05123612
Correlating Probiotic Dietary Supplements During Pregnancy With Maternal Microbiome Profiles
NCT03611647
Metabolomic Effects of Probiotics Administration
NCT04506385
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FertyBiotic Pregnancy
Participants received FertyBiotic Pregnancy one capsule a day
FertyBiotic Pregnancy
DHA, folic acid, Iodine, iron, Lactobacillus rhamnosus, Lactobacillus reuterii, magnesium, zinc, vitamin D3, Vitamin C, Vitamin E, Group B vitamins and Biotin
Control
400 mcg of folic acid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FertyBiotic Pregnancy
DHA, folic acid, Iodine, iron, Lactobacillus rhamnosus, Lactobacillus reuterii, magnesium, zinc, vitamin D3, Vitamin C, Vitamin E, Group B vitamins and Biotin
Control
400 mcg of folic acid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: \> 18 years old
* BMI \> 25
* Women who have signed the informed consent to participate in the study.
* No intention to change their routine physical activity or usual dietary intakes throughout the study
Exclusion Criteria
* Taking food supplements or probiotics
* History or current pathology that influence in the study
* With major fetal abnormalities
* Had used continuous antibiotic therapy for at least 3 months
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fertypharm
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Vithas Medimar
Alicante, Alicante, Spain
Centro Ginecologico Dra. García-Pérez Llantada
Zaragoza, Zaragoza, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020_FBE_04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.